 BEVERLY HILLS, Calif., Aug. 23, 2021 PRNewswire -- GT Biopharma, Inc. NASDAQ: GTBP, a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Companys proprietary natural killer NK cell engager, TriKE protein biologic technology platform, today announced the promotion of Gregory Berk, M.D. 